1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Perceptive Advisors Llc Buys Alexion Pharmaceuticals Inc, Biohaven Pharmaceutical Holding Co, Ascendis Pharma A/S, Sells AnaptysBio Inc, Puma Biotechnology Inc, Zimmer Biomet Holdings Inc

New York, NY, based Investment company Perceptive Advisors Llc buys Alexion Pharmaceuticals Inc, Biohaven Pharmaceutical Holding Co, Ascendis Pharma A/S, Menlo Therapeutics Inc, Abiomed Inc, La Jolla Pharmaceutical Co, Dova Pharmaceuticals Inc, DBV Technologies SA, Iovance Biotherapeutics Inc, Teladoc Inc, sells AnaptysBio Inc, Puma Biotechnology Inc, Zimmer Biomet Holdings Inc, AveXis Inc, Intuitive Surgical Inc during the 3-months ended 2018-03-31, according to the most recent filings of the investment company, Perceptive Advisors Llc. As of 2018-03-31, Perceptive Advisors Llc owns 134 stocks with a total value of $3.5 billion. These are the details of the buys and sells.

For the details of PERCEPTIVE ADVISORS LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=PERCEPTIVE+ADVISORS+LLC

These are the top 5 holdings of PERCEPTIVE ADVISORS LLC
  1. Neurocrine Biosciences Inc (NBIX) - 4,761,989 shares, 11.18% of the total portfolio. Shares reduced by 7.56%
  2. Amicus Therapeutics Inc (FOLD) - 20,024,424 shares, 8.53% of the total portfolio. Shares added by 11.94%
  3. Global Blood Therapeutics Inc (GBT) - 4,989,066 shares, 6.82% of the total portfolio. Shares added by 2.05%
  4. Zogenix Inc (ZGNX) - 3,970,357 shares, 4.5% of the total portfolio.
  5. Alnylam Pharmaceuticals Inc (ALNY) - 1,280,802 shares, 4.32% of the total portfolio. Shares reduced by 3.76%
New Purchase: Alexion Pharmaceuticals Inc (ALXN)

Perceptive Advisors Llc initiated holding in Alexion Pharmaceuticals Inc. The purchase prices were between $108.33 and $128.09, with an estimated average price of $119.53. The stock is now traded at around $121.55. The impact to a portfolio due to this purchase was 2.76%. The holding were 873,450 shares as of 2018-03-31.

New Purchase: Ascendis Pharma A/S (ASND)

Perceptive Advisors Llc initiated holding in Ascendis Pharma A/S. The purchase prices were between $38.98 and $68.04, with an estimated average price of $56.2. The stock is now traded at around $65.17. The impact to a portfolio due to this purchase was 1.82%. The holding were 982,647 shares as of 2018-03-31.

New Purchase: Menlo Therapeutics Inc (MNLO)

Perceptive Advisors Llc initiated holding in Menlo Therapeutics Inc. The purchase prices were between $28.51 and $37.82, with an estimated average price of $33.81. The stock is now traded at around $9.87. The impact to a portfolio due to this purchase was 1.7%. The holding were 1,598,958 shares as of 2018-03-31.

New Purchase: Teladoc Inc (TDOC)

Perceptive Advisors Llc initiated holding in Teladoc Inc. The purchase prices were between $31.3 and $44.05, with an estimated average price of $37.75. The stock is now traded at around $49.05. The impact to a portfolio due to this purchase was 0.59%. The holding were 520,000 shares as of 2018-03-31.

New Purchase: Agios Pharmaceuticals Inc (AGIO)

Perceptive Advisors Llc initiated holding in Agios Pharmaceuticals Inc. The purchase prices were between $59.83 and $86.53, with an estimated average price of $77.29. The stock is now traded at around $85.44. The impact to a portfolio due to this purchase was 0.58%. The holding were 250,000 shares as of 2018-03-31.

New Purchase: Adamas Pharmaceuticals Inc (ADMS)

Perceptive Advisors Llc initiated holding in Adamas Pharmaceuticals Inc. The purchase prices were between $23.67 and $42.65, with an estimated average price of $31.53. The stock is now traded at around $31.45. The impact to a portfolio due to this purchase was 0.43%. The holding were 630,000 shares as of 2018-03-31.

Added: Biohaven Pharmaceutical Holding Co Ltd (BHVN)

Perceptive Advisors Llc added to a holding in Biohaven Pharmaceutical Holding Co Ltd by 1021.05%. The purchase prices were between $22.49 and $34.56, with an estimated average price of $29.9. The stock is now traded at around $29.77. The impact to a portfolio due to this purchase was 1.84%. The holding were 2,927,449 shares as of 2018-03-31.

Added: Abiomed Inc (ABMD)

Perceptive Advisors Llc added to a holding in Abiomed Inc by 54.63%. The purchase prices were between $192.49 and $295.85, with an estimated average price of $253.43. The stock is now traded at around $380.35. The impact to a portfolio due to this purchase was 0.97%. The holding were 332,449 shares as of 2018-03-31.

Added: La Jolla Pharmaceutical Co (LJPC)

Perceptive Advisors Llc added to a holding in La Jolla Pharmaceutical Co by 27.30%. The purchase prices were between $28.17 and $39.24, with an estimated average price of $32.24. The stock is now traded at around $32.20. The impact to a portfolio due to this purchase was 0.78%. The holding were 4,313,611 shares as of 2018-03-31.

Added: Dova Pharmaceuticals Inc (DOVA)

Perceptive Advisors Llc added to a holding in Dova Pharmaceuticals Inc by 53.73%. The purchase prices were between $25 and $34.71, with an estimated average price of $29.97. The stock is now traded at around $26.18. The impact to a portfolio due to this purchase was 0.75%. The holding were 2,780,977 shares as of 2018-03-31.

Added: DBV Technologies SA (DBVT)

Perceptive Advisors Llc added to a holding in DBV Technologies SA by 113.92%. The purchase prices were between $20.86 and $26.6, with an estimated average price of $23.63. The stock is now traded at around $24.64. The impact to a portfolio due to this purchase was 0.73%. The holding were 2,093,498 shares as of 2018-03-31.

Added: Iovance Biotherapeutics Inc (IOVA)

Perceptive Advisors Llc added to a holding in Iovance Biotherapeutics Inc by 29.02%. The purchase prices were between $8.1 and $19.5, with an estimated average price of $15.14. The stock is now traded at around $15.25. The impact to a portfolio due to this purchase was 0.66%. The holding were 6,162,202 shares as of 2018-03-31.

Sold Out: Zimmer Biomet Holdings Inc (ZBH)

Perceptive Advisors Llc sold out a holding in Zimmer Biomet Holdings Inc. The sale prices were between $107.44 and $128.19, with an estimated average price of $119.62.

Sold Out: Tesaro Inc (TSRO)

Perceptive Advisors Llc sold out a holding in Tesaro Inc. The sale prices were between $55.23 and $78.84, with an estimated average price of $64.33.

Sold Out: Amgen Inc (AMGN)

Perceptive Advisors Llc sold out a holding in Amgen Inc. The sale prices were between $169.43 and $198, with an estimated average price of $183.57.

Sold Out: UroGen Pharma Ltd (URGN)

Perceptive Advisors Llc sold out a holding in UroGen Pharma Ltd. The sale prices were between $38.64 and $57.54, with an estimated average price of $50.09.

Sold Out: Regeneron Pharmaceuticals Inc (REGN)

Perceptive Advisors Llc sold out a holding in Regeneron Pharmaceuticals Inc. The sale prices were between $315.82 and $393.78, with an estimated average price of $347.81.

Sold Out: Antares Pharma Inc (ATRS)

Perceptive Advisors Llc sold out a holding in Antares Pharma Inc. The sale prices were between $1.93 and $2.79, with an estimated average price of $2.25.

Reduced: AnaptysBio Inc (ANAB)

Perceptive Advisors Llc reduced to a holding in AnaptysBio Inc by 68.63%. The sale prices were between $100.5 and $128.55, with an estimated average price of $112.73. The stock is now traded at around $89.32. The impact to a portfolio due to this sale was -1.74%. Perceptive Advisors Llc still held 237,281 shares as of 2018-03-31.

Reduced: Puma Biotechnology Inc (PBYI)

Perceptive Advisors Llc reduced to a holding in Puma Biotechnology Inc by 37.17%. The sale prices were between $59.7 and $99.25, with an estimated average price of $74.88. The stock is now traded at around $54.50. The impact to a portfolio due to this sale was -0.86%. Perceptive Advisors Llc still held 442,179 shares as of 2018-03-31.

Reduced: AveXis Inc (AVXS)

Perceptive Advisors Llc reduced to a holding in AveXis Inc by 42.43%. The sale prices were between $102.08 and $136.93, with an estimated average price of $118.65. The stock is now traded at around $217.83. The impact to a portfolio due to this sale was -0.75%. Perceptive Advisors Llc still held 276,400 shares as of 2018-03-31.

Reduced: Intuitive Surgical Inc (ISRG)

Perceptive Advisors Llc reduced to a holding in Intuitive Surgical Inc by 85.83%. The sale prices were between $375.25 and $449.81, with an estimated average price of $418.66. The stock is now traded at around $456.83. The impact to a portfolio due to this sale was -0.74%. Perceptive Advisors Llc still held 10,000 shares as of 2018-03-31.

Reduced: Teleflex Inc (TFX)

Perceptive Advisors Llc reduced to a holding in Teleflex Inc by 67.51%. The sale prices were between $242.67 and $287.65, with an estimated average price of $262.74. The stock is now traded at around $259.32. The impact to a portfolio due to this sale was -0.7%. Perceptive Advisors Llc still held 40,900 shares as of 2018-03-31.

Reduced: Regenxbio Inc (RGNX)

Perceptive Advisors Llc reduced to a holding in Regenxbio Inc by 38%. The sale prices were between $24.05 and $37.5, with an estimated average price of $29.15. The stock is now traded at around $50.95. The impact to a portfolio due to this sale was -0.6%. Perceptive Advisors Llc still held 881,106 shares as of 2018-03-31.



Here is the complete portfolio of PERCEPTIVE ADVISORS LLC. Also check out:

1. PERCEPTIVE ADVISORS LLC's Undervalued Stocks
2. PERCEPTIVE ADVISORS LLC's Top Growth Companies, and
3. PERCEPTIVE ADVISORS LLC's High Yield stocks
4. Stocks that PERCEPTIVE ADVISORS LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by insider


User Generated Screeners


rael2222CUCK AKRE 1
DBrizanall 2018Nov16 1250a
pbarker46Cheap dividend growth
mprimit0BTMA
dodozfmagicformulainvert
DBrizanCDN2018Nov14 914p
DBrizanall 2018Nov14 856p
blovedayShiller Cheap Basket not test
danccchanShort Selling
maxerGD stock selection 2
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK